| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 481,294 | 492,754 | 517,989 | 470,300 | | Cost of Revenue | 262,803 | 269,272 | 285,039 | 272,568 | | | Gross Profit | 218,491 | 223,482 | 232,950 | 197,732 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 154,679 | 159,402 | 162,316 | 159,385 | | Non Recurring | 852 | 255 | 803 | 1,866 | | Others | 8,011 | 8,429 | 8,453 | 8,665 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 54,949 | 55,396 | 61,378 | 27,816 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24 | 106 | 40 | 3,019 | | Earnings Before Interest And Taxes | 31,891 | 55,502 | 61,418 | 30,835 | | Interest Expense | (15,305) | 7,725 | 7,580 | 10,942 | | Income Before Tax | 47,196 | 47,777 | 53,838 | 19,893 | | Income Tax Expense | 17,743 | 18,920 | 21,534 | 6,929 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,453 | 28,857 | 32,304 | 12,964 | | | Non-recurring Events | | Discontinued Operations | (298) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,155 | 28,857 | 32,304 | 12,964 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,155 | $28,857 | $32,304 | $12,964 |
|
0.22% Nasdaq 
Income Statement
